When does this change take effect?

This change is effective Nov 20, 2025.

All PlansAdministrativeLow impact

2.01.92 - Fecal Microbiota Transplantation - name of bacteria was updated to Clostridioides (formerly Clostridium) difficile. Clarification on recurrent infection. Policy intent unchanged.

Q: Who is affected by this change?

This affects Blue Cross of Idaho Gastroenterology, Infectious Disease, Internal Medicine providers in ID on All Plans plans.

Blue Cross of Idaho·ID · Gastroenterology, Infectious Disease, Internal Medicine·Medical Policy

Effective date

Nov 20, 2025

We identified it

Jun 19, 2026

Days to comply

—

Summary

Policy 2.01.92 for Fecal Microbiota Transplantation updated the bacterial name from Clostridium to Clostridioides difficile and added clarification on recurrent infection criteria. The policy intent and coverage remain unchanged - this is a nomenclature update only.

Action Required

Action needed

By November 20, 2025: Update any documentation templates, billing software descriptions, or medical record forms to reference 'Clostridioides difficile' instead of 'Clostridium difficile' for FMT procedures. Review any prior authorization requests or clinical notes to ensure consistent bacterial nomenclature.

Related policy hubs

Blue Cross of Idaho policies ID policy changes Gastroenterology Infectious Disease Internal Medicine